GlassScriptPhysician profile
Robert A Gallino
NPI 1497762330
$14,735.72
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $394 · 2021: $856 · 2022: $448 · 2023: $1,275 · 2024: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,672.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $10,305.91 | 2019-2021 | |
| Philips North America LLC | $520.80 | 2019-2024 | (5028) Igt Devices Systems Undivided |
| Boston Scientific Corporation | $399.63 | 2019-2022 | |
| Abbott Laboratories | $353.34 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $309.13 | 2019-2024 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $287.01 | 2019-2024 | Farxiga, Brilinta, Lokelma |
| Merck Sharp & Dohme LLC | $279.86 | 2021-2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $252.10 | 2020-2024 | |
| Amgen INC. | $242.91 | 2021-2024 | Repatha |
| Pfizer INC. | $223.81 | 2019-2023 | |
| Shockwave Medical, INC | $218.49 | 2019-2021 | |
| Esperion Therapeutics, INC. | $163.76 | 2020-2023 | Nexletol |
| Amarin Pharma, INC. | $160.24 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $150.29 | 2023-2024 | Inpefa |
| Chiesi USA, INC. | $130.13 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $119.20 | 2022-2024 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $115.92 | 2019-2024 | Xarelto |
| Kiniksa Pharmaceuticals, LTD. | $75.17 | 2022-2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.13 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.40 | 2023 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $35.10 | 2019-2023 | Evkeeza |
| Actelion Pharmaceuticals US, INC. | $34.47 | 2023 | Opsumit, Uptravi |
| Penumbra, INC. | $34.26 | 2019 | |
| Medtronic Vascular, INC. | $30.29 | 2019 | |
| Terumo Medical Corporation | $26.78 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $21.63 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $19.97 | 2024 | Zio Xt Patch, Zio Monitor |
| Asahi Intecc USA, INC. | $19.10 | 2019 | |
| Ekos Corporation | $18.17 | 2019 | |
| Silk Road Medical, INC. | $17.59 | 2019 | |
| Abiomed | $17.10 | 2019 | |
| W. L. Gore & Associates, INC. | $15.22 | 2019 | |
| Cook Medical LLC | $14.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gallino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.